Business Context and Reporting Period
This Form 8-K filing by Ocular Therapeutix, Inc. reports material events occurring on June 17, 2016, and June 20, 2016. The company, a Delaware corporation, entered into a significant lease agreement for new facilities and amended its existing credit agreement to accommodate the new lease obligations.
Key Financial Metrics and Obligations
The filing details specific financial commitments related to the new lease and credit facility amendment:
- Lease Term: February 1, 2017, to July 31, 2027 (approximately 10.5 years).
- Initial Annual Base Rent: Approximately $1.2 million, with annual increases starting February 1 of each year.
- Rent Commencement: No base rent is due until August 1, 2017.
- Security Deposit: A letter of credit in the amount of approximately $1.5 million is required.
- Construction Allowance: Up to $2.8 million available for construction costs, with a forfeiture deadline of December 31, 2017.
- Operating Costs: The company is obligated to pay all real estate taxes and costs related to operations, maintenance, repair, and replacement.
The filing does not provide current revenue, profit, cash flow, or total debt figures.
Material Changes and Agreements
The primary material change is the execution of a lease for approximately 70,712 square feet of office, R&D, and manufacturing space at 15 Crosby Drive, Bedford, Massachusetts. The company intends to relocate its corporate headquarters to this location beginning in 2017 and move all operations there by 2018. Additionally, on June 20, 2016, the company amended its Credit and Security Agreement with MidCap Funding III Trust, Silicon Valley Bank, and Flexpoint MCLS SPV LLC to classify the new Security Deposit Letter of Credit as a "Permitted Lien."
Outlook, Risks, and Contingencies
Management intends to utilize the new premises to consolidate operations. A key contingency involves the construction allowance of $2.8 million; if not utilized by December 31, 2017, the allowance will be forfeited with no further obligation to the landlord. The filing notes that the full terms of the agreements are subject to the exhibits to be filed in the subsequent Form 10-Q.
Investor Verification Checklist
- Verify the total projected cost of the lease over the 10.5-year term, including annual rent escalations and estimated operating expenses.
- Confirm the company's current liquidity position to ensure it can fund the $1.5 million letter of credit and the $2.8 million construction allowance.
- Review the upcoming Form 10-Q for the full text of the Lease Agreement and the First Amendment to the Credit Agreement.
- Assess the timeline for the relocation of operations to ensure it aligns with the rent commencement date of August 1, 2017.